Other large studies, including a meta-analysis, have also suggested a small increase in CRC risk associated with BRCA1, while, in general, no consistent association has been observed for BRCA2 [2, 33, 39–41]. This evidence concerns the gene BRCA2 and colorectal carcinoma.